HUB Organoids

Hi LinkedIn Fam, Meet Nilofar, our incredible Biobank Manager! 🎉 Over the past 10 years, Nilofar has been a cornerstone of our team, growing from a lab assistant to leading our biobank. Her work in modeling cystic fibrosis in organoids has been instrumental in our journey. Today, she's at the helm of maintaining and expanding our vast collection of our living patient-derived organoid biobank. We believe our people are the heart of our growth, and Nilofar is a shining example of that. Stay tuned for more spotlights on our amazing team!

PDO Screen is back! And this time featuring the industry's most promosing proto-oncogene: KRAS! Our screening panel includes 30 patient-derived organoids from non-small cell lung, pancreatic and colorectal cancer and feature pivotal KRAS mutations associated with tumor biology. The registerations are open until September 13th! Know more by clicking on the link below https://bit.ly/4deH1ux #kras #cancer #tumorbiology #raspathway #oncology #organoidsforcancer

Huge win for HUB Organoids! 🏆 We're honored to receive Frost & Sullivan's 2024 Global Technology Innovation Leadership Award for our work in Organoid technology. This recognition validates our decade-long commitment to redefining drug development! Want to know more about the award, you can read the original PR here -> https://bit.ly/3WrqI83 #Innovation #DrugDiscovery #Stemcells #Organoids #Organoidtechnology #pharmanews

We're on a mission to make adult stem cell-derived organoids a go-to tool for biopharma researchers worldwide. Our expertise lies in creating customized disease models for areas where treatments are urgently needed. Need a patient-derived research model? We can help! We've supported tons of projects, and we're confident we can help you reach your next breakthrough. Let's chat about your specific needs --> https://bit.ly/3WlWcg2

We're officially on Scientist.com! 🎉 This means: ✨streamlined contracting process ✨reduced time to kickstart your organoid project ✨ Seamless collab, thanks to the user-friendly interface of the platform Interested? Head to our profile and book our available services at https://bit.ly/4cBM1cO

Our poster on assessing #ADC efficacy and specificity using patient-derived organoids is live now! Click here to download it --> https://bit.ly/3xLSxid

Oncology researchers,,, psst..we've something exciting coming for you soon! ✨🎉 . Stay tuned! 🤫

Huge win for HUB Organoids! 🏆 We're honored to receive Frost & Sullivan's 2024 Global Technology Innovation Leadership Award for our work in Organoid technology. This recognition validates our decade-long commitment to redefining drug development! Want to know more about the award, you can read the original PR here -> https://bit.ly/4bq5JqE #Innovation #DrugDiscovery #Stemcells #Organoids #Organoidtechnology #pharmanews

Bringing a groundbreaking technology like organoids to market is no small feat. It's been a decade of continuous learning, refining our approach, building an incredible team, and witnessing tremendous growth – all driven by our unwavering vision to deliver superior therapeutic solutions to patients. Today, we'd like to share a glimpse into our journey so far. #organoidtechnology #innovation #biotechnology #organoids #patientinthelab

Interesting developments in immunotherapy! We've developed our organoid- & immunce cell co-culture to study immunotherapy targeted towards myeloid cells. Discover the platform by downloading our poster --> https://bit.ly/4b1ufOy https://lnkd.in/dUx338fS #Immunotherapy #Research #Science #Innovation #Organoids #MyeloidCells #CancerTreatment #organoids